Search results for Recast Studio

The "Predicting Diabetes Onset" solution is a machine learning-based tool designed to forecast the likelihood of an individual developing diabetes. By analyzing various health metrics and patient data, it provides early warnings, enabling timely interventions to prevent or delay the onset of diabetes. Key Features and Functionality: - Machine Learning Algorithms: Utilizes advanced machine learning models to analyze patient data and predict diabetes risk. - Data Integration: Combines multiple health indicators, such as blood glucose levels, BMI, and family history, for comprehensive risk assessment. - User-Friendly Interface: Offers an intuitive platform for healthcare providers to input data and receive predictive insights. - Scalability: Designed to handle large datasets, making it suitable for both individual assessments and population-level studies. Primary Value and Problem Solved: This solution addresses the critical need for early detection of diabetes risk. By providing accurate predictions, it empowers healthcare professionals to implement preventive measures, reducing the incidence of diabetes-related complications and improving patient outcomes. Early intervention can lead to better management of health resources and a decrease in healthcare costs associated with diabetes treatment.

Kiosco is a retail CRM for food and beverage brands selling to independent retailers (delicatessens, wine shops, concept stores). It unifies sales data from Ankorstore, Faire, Cegid, Sellsy and Odoo, forecasts each store's reorder cycle, suggests a tailored talking point for every retailer and summarises call notes. A customisable public store locator and an open-access Datalab (F&B M&A deals, retail density studies) complete the toolkit. Database of 3,000+ brands and 15,000+ retailers. Built in Paris by The Ludic Company. Kiosco est le CRM retail des marques alimentaires qui vendent aux commerces indépendants : épiceries fines, cavistes, concept stores. Il réunit les ventes Ankorstore, Faire, Cegid, Sellsy ou Odoo, prévoit le réassort de chaque commerce, propose un angle d'appel adapté à chaque revendeur et résume les comptes rendus. Store locator public personnalisable et Datalab en accès libre. Plus de 3 000 marques et 15 000 commerces référencés.

Propensity US: Valentine's Day Jewelry is a specialized dataset designed to enhance machine learning models by providing comprehensive insights into consumer behavior and preferences related to Valentine's Day jewelry purchases. This dataset is particularly valuable for businesses aiming to understand and predict market trends, optimize inventory, and tailor marketing strategies during the Valentine's Day season. Key Features and Functionality: - Comprehensive Data Collection: The dataset encompasses a wide range of variables, including purchase histories, customer demographics, product preferences, and seasonal trends specific to Valentine's Day jewelry. - High-Quality Data: Curated to ensure accuracy and relevance, the dataset provides reliable information for training and validating machine learning models. - Scalability: Designed to support various analytical needs, from small-scale studies to large-scale enterprise applications. Primary Value and Problem Solved: By leveraging Propensity US: Valentine's Day Jewelry, businesses can gain actionable insights into consumer purchasing patterns during the Valentine's Day period. This enables more effective demand forecasting, personalized marketing campaigns, and improved customer engagement, ultimately leading to increased sales and customer satisfaction.

PlanGrow Lab is a renowned business plan consulting service provider that helps startups and small businesses with business and financial planning. Whether you need a detailed business plan or precise financial projections to launch your business, refine your existing strategy, secure funding, or apply for a business visa—PlanGrow Lab’s professionals provide customized solutions to meet your requirements. While they’ve got an extensive range of consulting services to offer, you may consider the following as their forte: Customized business plan writing Financial forecasting & planning Pitch deck creation Business plan review E2/L1 visa business plans Besides, their consultants can also help you with financial modeling, feasibility studies, market research, marketing plans, SBA lending, and more. If you need help with any of the mentioned services, you can surely get in touch with the PlanGrow Lab team. They have already raised over $42M in funding for their clients and can surely help you too. Get a free, 30-minute consultation and decide for yourself.

Clintelligence is an AI-powered platform designed to revolutionize clinical trial intelligence by analyzing protocols against a vast database of over 500,000 historical trials. It enables researchers and sponsors to predict risks, optimize trial designs, and accelerate the approval process through actionable insights. The platform offers two primary functionalities: 1. Protocol Analysis: Users can upload their clinical trial protocols to receive instant AI-driven analyses that compare them with similar historical trials. This feature helps identify potential risks, optimize endpoints, and predict success rates. Key aspects include: - Risk Assessment & Mitigation - Amendment Prediction - Enrollment Forecasting - Site Intelligence 2. Patient Trial Matching: Clintelligence assists patients in finding clinical trials that align with their specific conditions and eligibility criteria through AI-powered screening and location-based matching. Features encompass: - Intelligent Eligibility Screening - Location-Based Matching - Match Score Ranking - Direct Site Contact By providing comprehensive trial intelligence, Clintelligence addresses the challenges of designing successful clinical trials and connecting patients with appropriate studies. Its AI-driven insights lead to faster protocol optimization and improved risk prediction accuracy, ultimately enhancing the efficiency and success rates of clinical trials.

The "Feasibility Analysis of Cancer Trial" is a comprehensive solution designed to streamline the planning and execution of cancer clinical trials. By integrating advanced data analytics and cloud computing capabilities, this product enables researchers and healthcare professionals to assess the viability of proposed trials efficiently. It facilitates the evaluation of patient recruitment potential, resource allocation, and overall trial design, ensuring that studies are both scientifically sound and operationally feasible. Key Features and Functionality: - Data Integration: Aggregates and analyzes diverse datasets, including genomic, clinical, and imaging data, to provide a holistic view of trial feasibility. - Predictive Analytics: Utilizes machine learning algorithms to forecast patient enrollment rates and identify potential challenges in trial execution. - Resource Optimization: Assesses the availability and allocation of necessary resources, such as personnel, equipment, and facilities, to ensure efficient trial operations. - Regulatory Compliance: Ensures that trial designs adhere to ethical standards and regulatory requirements, facilitating smoother approval processes. - Collaborative Platform: Provides a centralized interface for stakeholders to collaborate, share insights, and make informed decisions throughout the trial planning phase. Primary Value and Problem Solved: The primary value of the "Feasibility Analysis of Cancer Trial" lies in its ability to reduce the time and cost associated with the initial stages of clinical trial planning. By offering predictive insights and comprehensive analyses, it helps researchers identify and mitigate potential obstacles early in the process. This proactive approach enhances the likelihood of successful trial outcomes, accelerates the development of new cancer therapies, and ultimately contributes to improved patient care.

FactoraERP is the manufacturing operating system for food and agro-processing factories. It replaces the spreadsheets, WhatsApp groups and standalone tools many plants still run on with one cloud platform. Production, inventory, quality, finance and the rest all work from a single record of what the plant actually did, from farm-gate intake to dispatch. Its integrated modules cover production management (recipes, batches, yields), material intake, inventory and warehouse management, procurement, quality control and lab testing, supply-chain traceability, HR and payroll, financial management and costing, and analytics. Mobile capture works offline at the weighbridge or in the field and syncs when the signal returns. Traceability is batch-level, from farm to dispatch. A built-in AI Factory Copilot answers questions about live factory data in plain language ("How much oil did we produce last week?"). It also forecasts demand, raw-material needs and yields, flags anomalies such as yield drops, cost spikes or unusual stock movements, writes board-ready reports and recommends next steps. FactoraERP is purpose-built for processors: tea (green-leaf weighing and grading), coffee (cherry intake and lot traceability), dairy (milk intake and lab tests), avocado and edible oil, macadamia, fruit export and packhouses, beverages, animal feed, cosmetics and packaging. Farmer and supplier management, crop contracts, grading and crop-to-product traceability are built in, not custom add-ons. It is designed for real-world operating conditions, with local currencies and taxes, mobile-money payments (e.g. M-Pesa), tax-authority e-invoicing (e.g. KRA eTIMS), role-based access, full audit trails and an isolated workspace per company. Standard onboarding gets a plant live in under 24 hours. Factora Studio adds no-code customisation of forms, fields and workflows. An optional IIoT module (Factora IoT) brings live sensor data from the plant floor into the same system. FactoraERP is built by Tamalaki Business Network Ltd in Nairobi, Kenya. It is priced per organisation, in KES for East Africa and USD internationally, with a 14-day free trial.

Propensity US: Have Arthritis is a comprehensive dataset designed to assist healthcare professionals, researchers, and data scientists in understanding and predicting arthritis prevalence across the United States. By leveraging this dataset, users can develop predictive models, conduct epidemiological studies, and enhance public health strategies related to arthritis. Key Features and Functionality: - Extensive Data Coverage: The dataset encompasses a wide range of demographic and health-related variables, providing a holistic view of arthritis prevalence across different regions and populations. - High-Quality Data: Sourced from reputable health surveys and databases, ensuring accuracy and reliability for research and analysis. - User-Friendly Format: Structured in a manner that facilitates easy integration with various analytical tools and platforms, streamlining the data analysis process. Primary Value and Problem Solved: Propensity US: Have Arthritis addresses the need for detailed and reliable data on arthritis prevalence, enabling users to: - Develop Predictive Models: Utilize the dataset to create models that forecast arthritis trends, aiding in proactive healthcare planning and resource allocation. - Conduct Epidemiological Research: Analyze patterns and risk factors associated with arthritis, contributing to a deeper understanding of the disease and its impact on various populations. - Enhance Public Health Strategies: Inform policy decisions and intervention programs aimed at reducing the burden of arthritis through targeted prevention and treatment efforts. By providing a robust foundation for analysis, Propensity US: Have Arthritis empowers users to make data-driven decisions that can lead to improved health outcomes and more efficient healthcare services.

**HumblebeeAI** is a full-service **AI product development studio** that helps organizations design, build, and deploy production-ready AI systems with measurable business impact. Founded in 2023, HumblebeeAI operates at the intersection of **applied artificial intelligence, automation, and human-centered innovation**, providing both technology and talent to drive the future of intelligent organizations. Our solutions are designed for companies that want to move beyond experimentation and bring AI into real operations. From data infrastructure and predictive models to custom AI agents and intelligent dashboards, we deliver end-to-end systems that are fast, ethical, and scalable. ### **1. AI Product Development** We build AI-driven products that automate, optimize, and create new forms of value. Our engineering teams specialize in: * **Custom AI Agents:** Context-aware agents for marketing, legal, HR, and analytics workflows. * **RAG & Knowledge Systems:** Retrieval-augmented generation pipelines connected to private or enterprise data. * **Predictive Analytics & Forecasting:** Demand, risk, and behavioral modeling for better business foresight. * **Computer Vision & Embedded AI:** Real-time vision systems for robotics, security, and industrial IoT. Each solution is built to integrate seamlessly with existing tools and adapt as the client grows. ### **2. AI Infrastructure & Automation** We establish the data and automation backbone needed for sustainable AI adoption. Our infrastructure work includes: * **ETL & Data Pipelines:** BigQuery and Airflow-based ingestion and transformation systems. * **MLOps & Model Lifecycle:** Automated training, versioning, and monitoring pipelines. * **Workflow Automation:** API and n8n-powered systems that remove repetitive human tasks. * **Environment Management:** Configurable multi-environment setups for dev, QA, and production. This approach allows clients to reduce operational friction, improve scalability, and accelerate experimentation cycles. ### **3. AI Talent & Knowledge Development** Through **HumblebeeAI Academy**, we train and deploy elite AI engineers globally. * **Talent Pipeline:** Structured growth from Soft Landing → Foundation → Growth-3. * **Corporate AI Upskilling:** Tailored learning programs for in-house teams. * **Research & Development:** Collaborative projects in NLP, Vision, and Edge AI. Since 2023, HumblebeeAI has delivered **40+ AI systems** across **Europe, Asia, and MENA**, helping clients reduce costs by up to **70%**, improve decision speed, and build AI-capable teams. We combine world-class engineering with ethical principles to make artificial intelligence truly human-aligned.

Offrs is an AI-driven platform designed to revolutionize real estate lead generation by predicting and identifying homeowners most likely to sell their properties within the next 12 months. By analyzing over 250 data points, Offrs enables real estate professionals to focus their marketing efforts on high-potential leads, thereby increasing efficiency and conversion rates. The platform offers a suite of tools that streamline the lead generation process, from initial prediction to final conversion, ensuring agents are the first point of contact for prospective sellers. Key Features and Functionality: - Predictive Analytics: Utilizes a proprietary algorithm to analyze extensive homeowner data, forecasting with over 70% accuracy which properties are likely to be listed for sale within the next year. - AI-Powered Lead Generation: Targets potential sellers through strategic online advertising campaigns on platforms like Google, effectively capturing high-quality leads. - Comprehensive Lead Management: Provides tools such as Territory Builder, Lead Feed, and Lead Capture to manage and nurture leads throughout the sales funnel. - Real-Time Data Access: Offers up-to-date homeowner contact information and market data, accessible by zip code, enabling targeted outreach. - Automated Marketing Campaigns: Delivers engaging email sequences with strong calls to action, designed to convert leads into active clients. Primary Value and Solutions Provided: Offrs addresses the challenge real estate professionals face in identifying and connecting with potential sellers by leveraging advanced AI and big data analytics. The platform's predictive capabilities allow agents to focus their efforts on homeowners most likely to sell, increasing the chances of being the first point of contact—a critical factor, as studies show that 75% of homeowners choose the first agent they speak with when deciding to list their home. By automating lead generation and management processes, Offrs not only saves time and resources but also enhances the overall effectiveness of real estate marketing strategies, leading to higher conversion rates and increased commissions.

Arficus introduces MEDHINI, the world's first Generative AI-based Software as a Medical Device (SaMD), designed to revolutionize healthcare diagnostics. MEDHINI offers rapid, accurate, and affordable diagnostic solutions across multiple medical specialties, including neurology, nephrology, cardiology, oncology, and pulmonology. By leveraging advanced deep-tech computer vision and natural language processing, MEDHINI achieves a clinical accuracy of 99.31%, reducing disease diagnosis time to just 53 seconds and costs to less than $7, even in remote areas globally. Key Features and Functionality: - Multi-Specialty Diagnostics: MEDHINI provides diagnostic capabilities across various medical fields, including neurology, nephrology, cardiology, oncology, and pulmonology. - Rapid and Accurate Results: Utilizing advanced AI algorithms, MEDHINI delivers diagnoses with 99.31% clinical accuracy in under a minute. - Cost-Effective Solutions: The platform reduces diagnostic costs to less than $7, making healthcare more accessible. - Non-Invasive Integration: MEDHINI seamlessly integrates with existing medical equipment, such as X-rays, CT scans, and ultrasounds, without direct patient contact. - Predictive Health Mapping: The system offers predictive triage for over 345 diseases, forecasting potential occurrences or recurrences over a five-year span based on current health data. - Virtual Clinical Trials: MEDHINI supports in-silico virtual clinical trials, including bioavailability/bioequivalence (BA/BE) studies and antimicrobial resistance (AMR) analysis, enhancing drug discovery and efficacy assessments. Primary Value and User Solutions: MEDHINI addresses critical challenges in healthcare by providing rapid, accurate, and affordable diagnostic solutions, particularly benefiting underserved and remote communities. Its integration with existing medical infrastructure ensures minimal disruption while enhancing diagnostic capabilities. The platform's predictive health mapping aids in early disease detection and prevention, improving patient outcomes. Additionally, MEDHINI's support for virtual clinical trials accelerates drug development processes, contributing to more efficient and effective healthcare solutions worldwide.

EC Innovations works for and with the innovators, dreamers, developers, and communicators that assimilate and embrace the diversity that is essential to international business. Since being founded in 1997, EC Innovations continues to empower communications for leading multinational enterprises across the globe. From digitally maturing organizations in highly-regulated industries to high technology startups rapidly transforming the way we live, precision matters in translation more than ever before.